192 related articles for article (PubMed ID: 9551719)
41. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
[TBL] [Abstract][Full Text] [Related]
42. Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry.
Holmberg M; Scheinin M; Kurose H; Miettinen R
Neuroscience; 1999; 93(4):1323-33. PubMed ID: 10501456
[TBL] [Abstract][Full Text] [Related]
43. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex.
Ho SL; Honner V; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):634-9. PubMed ID: 9686939
[TBL] [Abstract][Full Text] [Related]
44. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
O'Rourke MF; Blaxall HS; Iversen LJ; Bylund DB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
[TBL] [Abstract][Full Text] [Related]
45. Recombinant human alpha 2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands.
Halme M; Sjöholm B; Savola JM; Scheinin M
Biochim Biophys Acta; 1995 Apr; 1266(2):207-14. PubMed ID: 7742388
[TBL] [Abstract][Full Text] [Related]
46. Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase.
Pohjanoksa K; Jansson CC; Luomala K; Marjamäki A; Savola JM; Scheinin M
Eur J Pharmacol; 1997 Sep; 335(1):53-63. PubMed ID: 9371546
[TBL] [Abstract][Full Text] [Related]
47. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
49. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
Büscher R; Heeks C; Taguchi K; Michel MC
Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
[TBL] [Abstract][Full Text] [Related]
50. Prejunctional alpha2A-autoreceptors in the human gastric and ileocolic arteries.
Guimarães S; Figueiredo IV; Caramona MM; Moura D; Paiva MQ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):207-11. PubMed ID: 9750006
[TBL] [Abstract][Full Text] [Related]
51. Rilmenidine reveals differences in the pharmacological characteristics of prejunctional alpha2-adrenoceptors in the guinea-pig, rat and pig.
Ali A; Cheng HY; Ting KN; Wilson VG
Br J Pharmacol; 1998 Sep; 125(1):127-35. PubMed ID: 9776352
[TBL] [Abstract][Full Text] [Related]
52. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies.
Shiue C; Pleus RC; Shiue GG; Rysavy JA; Sunderland JJ; Cornish KG; Young SD; Bylund DB
Nucl Med Biol; 1998 Feb; 25(2):127-33. PubMed ID: 9468027
[TBL] [Abstract][Full Text] [Related]
54. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
Uhlén S; Porter AC; Neubig RR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1558-65. PubMed ID: 7996470
[TBL] [Abstract][Full Text] [Related]
55. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
56. α
Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
[TBL] [Abstract][Full Text] [Related]
57. Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.
Deupree JD; Hinton KA; Cerutis DR; Bylund DB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1215-27. PubMed ID: 8819505
[TBL] [Abstract][Full Text] [Related]
58. Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.
Paris A; Philipp M; Tonner PH; Steinfath M; Lohse M; Scholz J; Hein L
Anesthesiology; 2003 Oct; 99(4):889-95. PubMed ID: 14508322
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
[TBL] [Abstract][Full Text] [Related]
60. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
Galitzky J; Larrouy D; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
